Correction of vitamin D insufficiency with combined strontium ranelate and vitamin D3 in osteoporotic patients

Author:

Rizzoli R,Dawson-Hughes B,Kaufman J-M,Fardellone P,Brandi M L,Vellas B,Collette J,Reginster J-Y

Abstract

ObjectiveThis study aims to investigate the efficacy and safety of oral fixed-dose combination of strontium ranelate 2 g/vitamin D31000 IU daily vs strontium ranelate 2 g daily for correcting vitamin D insufficiency in osteoporosis.DesignA 6-month international, randomized, double-blind, parallel-group, phase 3 study.MethodsA total of 518 men and postmenopausal women aged ≥50 years with primary osteoporosis (T-score ≤−2.5s.d.) and serum 25-hydroxyvitamin D (25(OH)D) >22.5 nmol/l were included. Patients were allocated to strontium ranelate 2 g/vitamin D31000 IU daily (n=413) or strontium ranelate 2 g daily (n=105). The participants received calcium 1 g daily. The primary endpoint was serum 25(OH)D at last post-baseline evaluation during 3 months.ResultsBoth groups were comparable at baseline. Mean baseline of 25(OH)D was 44.1±14.6 nmol/l. After 3 months, the percentage of patients with 25(OH)D ≥50 nmol/l was higher with strontium ranelate/vitamin D3vs strontium ranelate (84 vs 44%,P<0.001; adjusted between-group odds ratio=6.7; 95% CI, 4.2–10.9). The efficacy of the fixed-dose combination on 25(OH)D was maintained at 6 months (86 vs 40%,P<0.001). Mean 25(OH)D was 65.1 and 49.5 nmol/l, respectively, after 3 months and 66.9 and 45.4 nmol/l after 6 months. Physical performance improved in both groups. Falls were 17 and 20% in the strontium ranelate/vitamin D3and strontium ranelate groups respectively. Parathyroid hormone levels were inversely correlated with 25(OH)D. No clinically relevant differences in safety were observed.ConclusionsThis study confirms the efficacy and safety of fixed-dose combination of strontium ranelate 2 g/vitamin D31000 IU for correction of vitamin D insufficiency in osteoporotic patients.

Publisher

Bioscientifica

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3